Associate researcher at Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College, China
Dr. Huijuan Song is an accomplished associate researcher at the Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College. Her groundbreaking work in biomedical engineering focuses on the development of light-responsive biomaterials for tumor immunotherapy and tissue regeneration. A pioneer in merging bioactive materials with adaptive immune regulation, Dr. Song has contributed significantly to cancer treatment innovation and regenerative medicine.
Profile
Scopus
Education📘
Dr. Song earned her academic qualifications from prestigious institutions, culminating in her current role at the Chinese Academy of Medical Sciences. Her educational journey laid the foundation for her interdisciplinary approach, integrating biomedical engineering, oncology, and regenerative biology.
Experience💼
With extensive experience leading and participating in national research projects, Dr. Song has spearheaded innovations in tumor immunotherapy and tissue repair. Her leadership in groundbreaking studies, including National Natural Science Foundation of China projects, demonstrates her expertise in interdisciplinary applications of biomedical materials.
Research Interests🔬
Dr. Song’s research revolves around immune-regulating biomaterials. Her focus includes designing bioactive materials that modulate the immune system during disease progression. By investigating adaptive immune responses and tissue immune microenvironments, she bridges the gap between fundamental research and clinical applications in oncology and regenerative medicine.
Awards🏆
Dr. Song’s achievements have been recognized through multiple awards, including grants from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her work exemplifies excellence in biomedical engineering and tumor immunotherapy.
Publications🖊
Dr. Song has authored numerous high-impact papers in renowned journals. Each reflects her innovative contributions to biomedical engineering:
“l-2-Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia-inducible factor-1α signaling pathway”
“Biodegradable Plant Oil-Based Bioadhesive with Ultrastrong Wet-Tissue Adhesion for Instant Sealing Hemostasis”
“Photopolymerized Multifunctional Hydrogel Loaded with Asiaticoside and Growth Factor for Accelerating Diabetic Wound Healing”
“Glutathione Depletion-Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy”
“Exploring the Role of Inulin in Targeting the Gut Microbiota: An Innovative Strategy for Alleviating Colonic Fibrosis Induced By Irradiation”
“Mesenchymal stem cell-derived extracellular vesicles targeting irradiated intestine exert therapeutic effects”
“NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway”
“Association of low-dose ionising radiation with site-specific solid cancers: Chinese medical X-ray workers cohort study, 1950-1995”
“Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR”
“Macrophage metabolism reprogramming EGCG-Cu coordination capsules delivered in polyzwitterionic hydrogel for burn wound healing and regeneration”
These works have collectively received hundreds of citations, solidifying her position as a thought leader in biomedical research.
Conclusion🌟
Huijuan Song is an exceptional candidate for the Best Researcher Award under the World Biophotonics Research Awards program. Her innovative research, impactful publications, and translational potential make her a leading figure in the field of biomedical engineering. Strengthening her global collaborations and highlighting the biophotonics aspects of her work could further solidify her candidacy. Given her outstanding accomplishments and alignment with the award’s goals, she is highly deserving of this recognition.